Indeed, estrogen (E2)-induced chronic CREB signaling pathway activation with aberrant aromatase activity and metabolic disorders have been found in in vitro studies of mature GCs from women with PCOS [166–168]. Here, CYP19A1 is linked to polycystic ovary syndrome.